Abstract
Lenvatinib is a type I tyrosine kinase inhibitor exhibiting powerful antiangiogenic activity in cancer therapy. Displaying activity in multiple solid ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
